Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/167049
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Dysfunctional Skin-Derived Glucocorticoid Synthesis Is a Pathogenic Mechanism of Psoriasis |
Autor: | Hannen, R.; Udeh-Momoh, C.; Upton, J.; Wright , M.; Michael, A.; Gulati, A.; Rajpopat, S.; Clayton, N.; Yeo, L.; Halsall, D.; Burrin, J.; Flower, R.; Sevilla, Lisa M. CSIC ORCID; Latorre, V.; Frame, J.; Lightman, S.; Pérez, Paloma CSIC ORCID ; Philpott, M. | Fecha de publicación: | ago-2017 | Editor: | Elsevier | Citación: | Journal of Investigative Dermatology 137(8):1630-1637 (2017) | Resumen: | Glucocorticoids (GC) are the primary steroids that regulate inflammation and have been exploited therapeutically in inflammatory skin diseases. Despite the broad-spectrum therapeutic use of GC, the biochemical rationale for locally treating inflammatory skin conditions is poorly understood, as systemic GC production remains largely functional in these patients. GC synthesis has been well characterized in healthy skin, but the pathological consequence has not been examined. Here we show de novo GC synthesis, and GC receptor expression is dysfunctional in both nonlesional and lesional psoriatic skin. Use of GC receptor epidermal knockout mice with adrenalectomy allowed for the distinction between local (keratinocyte) and systemic GC activity. Compensation exhibited by adult GC receptor epidermal knockout mice demonstrated that keratinocyte-derived GC synthesis protected skin from topical phorbol 12-myristate 13-acetate-induced inflammatory assault. Thus, localized de novo GC synthesis in skin is essential for controlling inflammation, and loss of the GC pathway in psoriatic skin represents an additional pathological process in this complex inflammatory skin disease. | Descripción: | 8 Pages, 4 Figures | Versión del editor: | http://dx.doi.org/10.1016/j.jid.2017.02.984 | URI: | http://hdl.handle.net/10261/167049 | DOI: | 10.1016/j.jid.2017.02.984 | ISSN: | 0022-202X | E-ISSN: | 1523-1747 |
Aparece en las colecciones: | (IBV) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
2017 J Invest Dermatol 137-1630.pdf | Versión Pre-Print del artículo | 291,77 kB | Adobe PDF | Visualizar/Abrir |
2017 J Invest Dermatol 137-1630-Fig1.pdf | Figura 1 | 2,44 MB | Adobe PDF | Visualizar/Abrir |
2017 J Invest Dermatol 137-1630-Fig2.pdf | Figura 2 | 3,21 MB | Adobe PDF | Visualizar/Abrir |
2017 J Invest Dermatol 137-1630-Fig3.pdf | Figura 3 | 7,2 MB | Adobe PDF | Visualizar/Abrir |
2017 J Invest Dermatol 137-1630-Fig4.pdf | Figura 4 | 1,63 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
31
checked on 13-abr-2024
WEB OF SCIENCETM
Citations
32
checked on 23-feb-2024
Page view(s)
309
checked on 22-abr-2024
Download(s)
438
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.